Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
W.R. Berkley Corp. ( WRB - Analyst Report ) announced that its Board has increased its share repurchase authorization to 10 million shares. This translates into approximately 7% of the company’s outstanding shares as of June 30, 2011.
Share buybacks increase a company’s earnings per share by reducing the number of shares outstanding. This step is also indicative of the fact that the company’s financial position is strong enough to enhance its shareholders’ value.
Berkley has been aggressively repurchasing shares for quite some time. Since 2007, it has bought back about 30% of its outstanding shares.
The latest share repurchase marks the first share buyback program adopted by the company for this year. The last time it took a similar action was in November 2011.
Berkley has been actively involved in share buybacks to support its bottom line amid weak property and casualty market. The company is facing premium declines since the onset of soft market conditions in 2006. To position itself for growth, the company has made a number of investments and started 21 new units in the last three years.
Though the company has witnessed improvements in insurance rates in certain lines of businesses, a sustainable turnaround in the underwriting cycle is yet to be seen. Low interest rates are adversely affecting its profitability, by limiting return on investment. Until these conditions improve, we expect the company to continue taking defensive actions like share buybacks.
On the other hand, the company announced a regular quarterly dividend of 9 cents per share, which was raised by 36% during last quarter. Dividends at Berkley have increased at a 5-year CAGR of 24%.
We maintain our Neutral recommendation on W.R. Berkley. The stock also retains a Zacks #3 Rank, which translates into a short-term Hold rating.
Berkley competes closely with a host of property and casualty carriers, such as The Chubb Corp. ( CB - Analyst Report ) , The Travelers Companies, Inc. ( TRV - Analyst Report ) , XL Group plc ( XL - Analyst Report ) and The Allstate Corp. (ALL).
Read the full Analyst Report on WRB
Read the full Analyst Report on XL
Read the full Analyst Report on TRV
Read the full Analyst Report on CB